THE ROLE OF ARTIFICIAL INTELLIGENCE IN THE DIAGNOSIS OF CHRONIC HEART FAILURE
Keywords:
Artificial Intelligence, Chronic Heart Failure, Echocardiography, Deep Learning, Electrocardiogram, Phenomapping, HFpEF, Clinical Decision Support SystemsAbstract
Artificial intelligence (AI) is transforming the diagnostic paradigm of chronic heart failure (HF) by improving early detection, standardizing imaging interpretation, and unraveling patient heterogeneity. Machine learning and deep learning models automate chamber segmentation and ejection fraction calculation in echocardiography, reducing manual burden and inter-observer variability. In electrocardiography (ECG), deep neural networks identify subclinical signatures of structural heart disease, acting as digital biomarkers capable of predicting HF risk years in advance. Furthermore, unsupervised learning techniques like phenomapping successfully categorize complex clinical syndromes, such as heart failure with preserved ejection fraction (HFpEF), into distinct, targeted subgroups. Integrated into Electronic Health Records via Clinical Decision Support Systems (AI-CDSS), AI synthesizes multidimensional medical data to provide real-time, personalized diagnostic insights, shifting heart failure management from reactive treatment to proactive, preventive care.References
1. National Center for Biotechnology Information (NCBI). Artificial Intelligence in Cardiovascular Imaging: Current State and Future Directions. Bethesda, MD: National Library of Medicine. Available from: https://www.ncbi.nlm.nih.gov/
2. Topol, E. J. (2019). High-performance medicine: the convergence of human and artificial intelligence. Nature Medicine, 25(1), 44–56. https://doi.org/10.1038/s41591-018-0300-7
3. Attia, Z. I., Kapa, S., Lopez-Jimenez, F., et al. (2019). Screening for cardiac contractile dysfunction using an artificial intelligence–enabled electrocardiogram. Nature Medicine, 25(1), 70–74. https://doi.org/10.1038/s41591-018-0240-2
4. Shah, S. J., Katz, D. H., Selvaraj, S., et al. (2015). Phenomapping for the identification of phenogroups in heart failure with preserved ejection fraction. Circulation, 131(3), 269–279. https://doi.org/10.1161/CIRCULATIONAHA.114.013215
5. Benjamin, E. J., Meschia, J. F., Callaway, C. W., et al. (2019). Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association. Circulation, 139(10), e56–e528. https://doi.org/10.1161/CIR.0000000000000659